Skip to main content

Genesis Healthcare

corporate_fare Company Profile

Genesis Healthcare

GENNQ·OTC·Trade & Services·CIK 0001351051

Genesis Healthcare is a holding company whose subsidiaries collectively form one of the largest post-acute care providers in the United States. The company offers inpatient services, rehabilitation and respiratory therapy services, and a full range of administrative services to its affiliated operators through its administrative services subsidiaries. Genesis Healthcare also provides management services to third-party operators under contract through its management services subsidiary. The healthcare operating subsidiaries prioritize providing quality care, with skilled nursing facility subsidiaries forming the largest part of the consolidated business. These facilities are dedicated to treating high-acuity patients who need a high level of skilled nursing care and extensive rehabilitation therapy. Genesis Healthcare's services primarily address the medical and physical needs of elderly patients. These services are delivered by employees of its skilled nursing facilities, assisted/senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services. As of December 31, 2020, the company had three reportable operating segments: (1) inpatient services, which includes the operation of skilled nursing facilities and assisted/senior living facilities and represents the largest portion of the business; (2) rehabilitation therapy services, encompassing integrated and third-party rehabilitation and respiratory therapy services; and (3) all other services. For the year ended December 31, 2020, the inpatient services segment generated approximately 86% of the company's revenue, the rehabilitation therapy services segment generated approximately 10% of revenue, and all other services accounted for the remaining balance.

Genesis Healthcare (OTC:GENNQ) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 3 items for GENNQ at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-14, rated 8/10. Across its 3 most recent items scored 7 or higher, the top rating is 8/10, with 3 rated 8 or above.

Recent high-impact activity:

  • Genesis Healthcare Exits Chapter 11, Closes $1B Asset Sale to NewGen
  • Genesis Healthcare Wins Court Approval for $1B Bankruptcy Sale
  • Genesis Healthcare Settles Insider Dispute, Unsecured Creditors to Get $150M Cash

Financial Snapshot

Fiscal year ended December 31, 2020
Revenue
$3.91B
Net Income
-$58.96M
Diluted EPS
-$0.53
Op. Cash Flow
$315.73M
Free Cash Flow
$108.42M
Cash & Equivalents
$212.07M
Total Debt
$1.54B
Debt / Equity
-1.88×
Net Margin
-1.5%
Shares Outstanding
111.85M sh
Source: 10-K · filed 2021-03-16 · accession 0001558370-21-003091
$0.000001
Market cap
$175
Volume
7.8K (0.7× avg)
3-mo avg 11.6K
Last traded · 2026-10-27

show_chartPrice Chart

Loading chart...

feed GENNQ - Latest Insights

GENNQ
Oct 14, 2026, 2:59 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.000001
Real-time Price: $0.000001 info
Change: N/A info
Market Cap: $175 info
GENNQ
Oct 08, 2026, 7:18 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.000001
Real-time Price: $0.000001 info
Change: N/A info
Market Cap: $175 info
GENNQ
Aug 19, 2026, 8:48 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.0002
Real-time Price: $0.000001 info
Change: -$0.000199 (-100%) info
Market Cap: $175 info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets